American Heart Technologies (AHT) was founded by Dr. Morteza Naghavi as a vehicle to transition innovative healthcare ideas into commercially viable solutions for the prevention and treatment of cardiovascular diseases. Dr. Naghavi has over 30 issued and pending patents in medical technologies mostly focused on cardiovascular care. In collaborations with leading cardiologists, he has lead a number of pioneering initiatives. At the core of AHT, is a strong commitment to innovate and invest in affordable solutions for patient care. The main focus of AHT is on early detection and treatment of sub-clinical cardiovascular diseases as well as home-based consumer-centered preventive healthcare and wellness solutions empowered by artificial intelligence and robotic technologies.